Compare J.B.Chemicals with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs GSK PHARMA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS GSK PHARMA J.B.CHEMICALS/
GSK PHARMA
 
P/E (TTM) x 21.7 211.1 10.3% View Chart
P/BV x 3.9 10.9 36.0% View Chart
Dividend Yield % 0.3 1.5 20.7%  

Financials

 J.B.CHEMICALS   GSK PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
GSK PHARMA
Mar-19
J.B.CHEMICALS/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs3633,595 10.1%   
Low Rs2551,253 20.4%   
Sales per share (Unadj.) Rs169.1184.7 91.6%  
Earnings per share (Unadj.) Rs16.626.3 63.1%  
Cash flow per share (Unadj.) Rs23.429.2 80.3%  
Dividends per share (Unadj.) Rs2.0020.00 10.0%  
Dividend yield (eoy) %0.60.8 78.4%  
Book value per share (Unadj.) Rs172.5126.3 136.6%  
Shares outstanding (eoy) m83.57169.40 49.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.813.1 13.9%   
Avg P/E ratio x18.692.2 20.2%  
P/CF ratio (eoy) x13.283.1 15.9%  
Price / Book Value ratio x1.819.2 9.3%  
Dividend payout %12.076.1 15.8%   
Avg Mkt Cap Rs m25,827410,626 6.3%   
No. of employees `0003.85.0 76.0%   
Total wages/salary Rs m2,5115,372 46.7%   
Avg. sales/employee Rs Th3,747.46,306.7 59.4%   
Avg. wages/employee Rs Th665.71,083.1 61.5%   
Avg. net profit/employee Rs Th367.8898.0 41.0%   
INCOME DATA
Net Sales Rs m14,13531,281 45.2%  
Other income Rs m3661,023 35.8%   
Total revenues Rs m14,50132,304 44.9%   
Gross profit Rs m2,1786,009 36.3%  
Depreciation Rs m570486 117.2%   
Interest Rs m356 581.7%   
Profit before tax Rs m1,9406,540 29.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0287 0.0%   
Tax Rs m5522,373 23.3%   
Profit after tax Rs m1,3874,454 31.1%  
Gross profit margin %15.419.2 80.2%  
Effective tax rate %28.536.3 78.5%   
Net profit margin %9.814.2 68.9%  
BALANCE SHEET DATA
Current assets Rs m10,47020,061 52.2%   
Current liabilities Rs m2,74914,543 18.9%   
Net working cap to sales %54.617.6 309.6%  
Current ratio x3.81.4 276.1%  
Inventory Days Days5557 97.2%  
Debtors Days Days7814 552.3%  
Net fixed assets Rs m5,81114,343 40.5%   
Share capital Rs m1671,694 9.9%   
"Free" reserves Rs m14,24819,704 72.3%   
Net worth Rs m14,41621,398 67.4%   
Long term debt Rs m02 0.0%   
Total assets Rs m17,64939,113 45.1%  
Interest coverage x56.61,091.0 5.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.8 100.1%   
Return on assets %8.111.4 70.7%  
Return on equity %9.620.8 46.2%  
Return on capital %13.731.9 42.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,164534 1,154.3%   
Fx outflow Rs m1,3347,091 18.8%   
Net fx Rs m4,829-6,557 -73.7%   
CASH FLOW
From Operations Rs m1,2313,994 30.8%  
From Investments Rs m-208-1,433 14.5%  
From Financial Activity Rs m-595-3,584 16.6%  
Net Cashflow Rs m427-1,023 -41.7%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 50.7 0.6%  
Indian inst/Mut Fund % 3.4 10.2 33.2%  
FIIs % 3.9 23.8 16.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 15.4 240.3%  
Shareholders   30,437 102,036 29.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  NOVARTIS  PANACEA BIOTECH  

Compare J.B.CHEMICALS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

SGX Nifty Trades Positive, Crude Oil Sees Buying, FPI Equity Inflows Rise, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended marginally lower yesterday as benchmark indices gave up early gains and slipped into the red during the last hour of trading.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

Protect Your Wealth from Fund Managers(Fast Profits Daily)

May 14, 2020

Do you know how much you are paying in fees to your mutual fund? In this video I'll share with you my views.

How Commodity Prices Tell You When Stocks Will Go Up(Fast Profits Daily)

May 20, 2020

Commodity prices often provide clues to big moves in stock markets. In today's video, I'll explain this link.

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

Why Buffet - and you - should study Quantum Liquid Fund(The Honest Truth)

May 14, 2020

Ajit Dayal on how Quantum Liquid Fund and Warren Buffett have similar investing styles.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


May 26, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - AJANTA PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS